Search

everythinglearnresearchcommunity

for

Search:↓

Follicular unit extraction is safe and effective without bupivacaine and nerve blocks when using lignocaine with adrenaline.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Certain microRNAs may protect against hair loss in alopecia areata and could be potential treatment targets.

A man's red tattoo caused a skin reaction and hair loss in his beard, which improved after treatment.

Minoxidil and PRP can help convert miniaturized hair follicles back to normal in male pattern baldness.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

The combined treatment helps improve severe hair loss and reduces the need for other medications.

Dermal IgA deposition without symptoms is rare in Dermatitis herpetiformis risk groups.

Allergen-specific immunotherapy can significantly improve hair loss and dermatitis symptoms in severe cases.

Diphencyprone (DCP) is an effective treatment for severe alopecia areata and resistant warts, with some risks.

Further trials are needed to explore the efficacy of triamcinolone acetonide in dermatology.

Toluene diisocyanate exposure can cause immune sensitization by interacting with proteins in hair follicles and sebaceous glands.

Allergen desensitization reduces hair loss severity in dust-mite allergic alopecia areata patients.

Atopic dermatitis shows a link between skin layers in inflammation, detectable with detailed gene analysis.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.

Allergies, especially dust mite allergy, may worsen alopecia areata, and desensitization could help reduce its severity.

Topical immunotherapy for alopecia areata may work by creating immune cell clusters in the skin.

Recognizing new allergens can help reduce contact dermatitis cases.

Transepidermal drug delivery effectively treated areata alopecia with minimal side effects.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Traditional Chinese medications can cause skin reactions, and better testing and reporting are needed to identify allergens.

Gamma/delta T cells help defend skin against heavy metals.

Switching insulin brands caused skin lesions in a diabetic woman, resolved by changing to oral medication.

Avoiding allergens can improve skin and hair conditions in adults with allergic reactions.

Squaric acid dibutylester can cause severe skin reactions in people with allergies.

Topical immunotherapy is more effective than dapsone for treating severe alopecia areata.

Dithranol reduces inflammation in alopecia areata by lowering certain immune responses.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Diphenylcyclopropenone (DPCP) is more effective than anthralin for treating resistant alopecia areata.